Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 149 citing articles:

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson, Ellen Snyder, Erin M. Paradis, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 5, pp. 461-471
Closed Access | Times Cited: 480
Sleep and Alzheimer's disease
Laure Peter‐Derex, Pierre Yammine, Hélène Bastuji, et al.
Sleep Medicine Reviews (2014) Vol. 19, pp. 29-38
Closed Access | Times Cited: 391
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy, Margaret Moline, David Mayleben, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 11, pp. 1289-1299
Open Access | Times Cited: 298
Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Leslie Citrome
International Journal of Clinical Practice (2014) Vol. 68, Iss. 12, pp. 1429-1441
Open Access | Times Cited: 246
Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies
Danielle K. Sandsmark, Jonathan E. Elliott, Miranda M. Lim
SLEEP (2017)
Open Access | Times Cited: 172
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Christopher J. Winrow, John J. Renger
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 283-293
Open Access | Times Cited: 144
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis
Almira Chabi, Ying Zhang, Saheeda Jackson, et al.
Cephalalgia (2014) Vol. 35, Iss. 5, pp. 379-388
Closed Access | Times Cited: 103
Circadian Rhythm and Alzheimer’s Disease
Jan Homolak, Monika Mudrovčić, Barbara Vukić, et al.
Medical Sciences (2018) Vol. 6, Iss. 3, pp. 52-52
Open Access | Times Cited: 91
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 19, pp. 7590-7607
Closed Access | Times Cited: 96
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 72
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
W. Joseph Herring, Kathleen M. Connor, Ellen Snyder, et al.
Journal of Clinical Sleep Medicine (2016) Vol. 12, Iss. 09, pp. 1215-1225
Open Access | Times Cited: 71
The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
Alexander Treiber, Ruben de Kanter, Catherine Roch, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 3, pp. 489-503
Open Access | Times Cited: 69
DEC2 modulates orexin expression and regulates sleep
Arisa Hirano, Pei-Ken Hsu, Luoying Zhang, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 13, pp. 3434-3439
Open Access | Times Cited: 69
Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea
Hong Sun, John Palcza, Deborah Card, et al.
Journal of Clinical Sleep Medicine (2016) Vol. 12, Iss. 01, pp. 9-17
Open Access | Times Cited: 67
Suvorexant
Kunal V. Patel, Anthony V. Aspesi, Kirk E. Evoy
Annals of Pharmacotherapy (2015) Vol. 49, Iss. 4, pp. 477-483
Closed Access | Times Cited: 65
Page 1 - Next Page

Scroll to top